HealthDay News — Almost 1 in 5 patients with cirrhosis receive opioid prescriptions during outpatient visits, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, held virtually from November 12 to 15.

Anna Lee, MD, from University of California in Los Angeles, and colleagues used data from the National Ambulatory Medical Care Survey (10.1 million ambulatory visits from 2006 to 2016) to assess national opioid prescription patterns in patients with cirrhosis.

The researchers found that 17% of visits were associated with an opioid prescription, the majority of which (91%) were for opioid prescription renewals. The most frequently prescribed opioids were oxycodone (35%) and hydrocodone (25%). Most of the opioid visits were with primary care providers (68%), and 29% were with gastroenterologists. A documented pain diagnosis was made in 41% of visits associated with an opioid prescription, including most commonly musculoskeletal (34%) and gastrointestinal (28%) pain.

“Since most opioid prescriptions are associated with primary care visits, we should target our educational efforts about harms toward primary care providers,” Lee said in a statement. “All clinicians can benefit from more education about safe options for managing pain disorders.”


Continue Reading

Press Release

More Information